Xin Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xin Huang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Zhaoming Ye
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, China
11 shared publications - Nong Lin
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
9 shared publications - Xiaobo Yan
The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang People's Republic of China
7 shared publications - Donghua Huang
Hospital for Special Surgery
6 shared publications - Meng Liu
The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang People's Republic of China
4 shared publications - Binghao Li
Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Wolters Kluwer Health in Spine
Early Ambulation Accelerates Time to First Bowel Movement After Separation Surgery for Spinal Tumors
Study Design.: Retrospective cohort study. Objective.: To identify factors associated with the timing of bowel function recovery after separation surgery for metastatic spinal tumors, while incorporating the temporal dimension of postoperative rehabilitation Summary of Background Data.: Separation surgery for metastatic spinal tumors is more extensive compared to conventional spinal surgery and carries a higher risk of postoperative ileus (POI). However, the factors influencing bowel recovery following this procedure remain poorly understood. Prior studies on conventional spinal decompression typically characterize bowel outcomes as binary events, neglect temporal recovery kinetics, and may introduce reverse causation bias. Methods.: A retrospective analysis was conducted on patients who underwent separation surgery for metastatic spinal tumors at our institution (2021-2025). Clinical characteristics, postoperative ambulation status (including the status and time to first ambulation), and bowel movement outcomes (comprising the occurrence and postoperative time to first bowel movement) were collected. The primary endpoint was time to first postoperative bowel movement. Univariable and multivariable time-dependent Cox proportional hazards models were performed, with the time to first postoperative bowel movement serving as the primary outcome, and ambulation status modeled as a time-dependent covariate. Results.: A total of 153 patients were included (median age 62 years [IQR, 57–69]; 64.7% male). During hospitalization, 134 patients (87.6%) achieved postoperative bowel movement, occurring at a mean of 4.0±1.9 days after surgery. In multivariable Cox regression analysis, postoperative ambulation was independently associated with earlier bowel recovery (HR, 5.69; 95% CI, 3.03–10.69; P P =0.007) and greater postoperative 24-hour opioid consumption (per 10-MME increase: HR, 0.45; 95% CI, 0.35–0.57; P <0.001) were associated with delayed bowel recovery. Tumor origin, involvement pattern, ESCC grade, pathological fracture, surgical region, fixation levels, and decompression levels were not significantly associated with bowel recovery. Conclusion.: Early postoperative ambulation was associated with faster bowel recovery after spinal tumor separation surgery, supporting its incorporation into postoperative rehabilitation strategies. Postoperative opioid management may require balancing adequate analgesia to facilitate mobilization against potential adverse effects on bowel recovery. Level of Evidence.: Level III.
- 12 October 2026
- Published by Wolters Kluwer Health in Spine
Open AccessEarly Ambulation Accelerates Time to First Bowel Movement After Separation Surgery for Spinal Tumors
Study Design.: Retrospective cohort study. Objective.: To identify factors associated with the timing of bowel function recovery after separation surgery for metastatic spinal tumors, while incorporating the temporal dimension of postoperative rehabilitation Summary of Background Data.: Separation surgery for metastatic spinal tumors is more extensive compared to conventional spinal surgery and carries a higher risk of postoperative ileus (POI). However, the factors influencing bowel recovery following this procedure remain poorly understood. Prior studies on conventional spinal decompression typically characterize bowel outcomes as binary events, neglect temporal recovery kinetics, and may introduce reverse causation bias. Methods.: A retrospective analysis was conducted on patients who underwent separation surgery for metastatic spinal tumors at our institution (2021-2025). Clinical characteristics, postoperative ambulation status (including the status and time to first ambulation), and bowel movement outcomes (comprising the occurrence and postoperative time to first bowel movement) were collected. The primary endpoint was time to first postoperative bowel movement. Univariable and multivariable time-dependent Cox proportional hazards models were performed, with the time to first postoperative bowel movement serving as the primary outcome, and ambulation status modeled as a time-dependent covariate. Results.: A total of 153 patients were included (median age 62 years [IQR, 57–69]; 64.7% male). During hospitalization, 134 patients (87.6%) achieved postoperative bowel movement, occurring at a mean of 4.0±1.9 days after surgery. In multivariable Cox regression analysis, postoperative ambulation was independently associated with earlier bowel recovery (HR, 5.69; 95% CI, 3.03–10.69; P P =0.007) and greater postoperative 24-hour opioid consumption (per 10-MME increase: HR, 0.45; 95% CI, 0.35–0.57; P <0.001) were associated with delayed bowel recovery. Tumor origin, involvement pattern, ESCC grade, pathological fracture, surgical region, fixation levels, and decompression levels were not significantly associated with bowel recovery. Conclusion.: Early postoperative ambulation was associated with faster bowel recovery after spinal tumor separation surgery, supporting its incorporation into postoperative rehabilitation strategies. Postoperative opioid management may require balancing adequate analgesia to facilitate mobilization against potential adverse effects on bowel recovery. Level of Evidence.: Level III.
- 18 July 2026
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- p. 1-20
Localized and sustained release of Puerarin from a calcium phosphate hydrogel enhances immunomodulatory bone repair by modulating pro-healing macrophage phenotype transitions
The escalating global incidence of bone defects, attributable to factors such as infections, tumor resections, and fractures accompanied by extensive soft tissue damage, represents a considerable e...
- 18 July 2026
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- p. 1-20
Localized and sustained release of Puerarin from a calcium phosphate hydrogel enhances immunomodulatory bone repair by modulating pro-healing macrophage phenotype transitions
The escalating global incidence of bone defects, attributable to factors such as infections, tumor resections, and fractures accompanied by extensive soft tissue damage, represents a considerable e...
- Top Cited PapersOpen Access
- 5 January 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 2
The roles of the nerve-immune axis in modulating bone regeneration
Bone is highly innervated, and its regeneration is significantly nerve-dependent. Extensive evidence suggests that the nervous system plays an active role in bone metabolism and development by modulating osteoblast and osteoclast activity. However, the majority of research to date has focused on the direct effects of peripheral nerves and their neurotransmitters on bone regeneration. Emerging studies have begun to reveal a more intricate role of nerves in regulating the immune microenvironment, which is crucial for bone regeneration. This review summarizes how nerves influence bone regeneration through modulation of the immune microenvironment. We first discuss the changes in peripheral nerves during the regenerative process. We then describe conduction and paracrine pathways through which nerves affect the osteogenic immune microenvironment, emphasizing nerves, neural factors, and their impacts. Our goal is to deepen the understanding of the nerve-immune axis in bone regeneration. A better grasp of how nerves influence the osteogenic immune microenvironment may lead to new strategies that integrate the nervous, immune, and skeletal systems to promote bone regeneration.
- 5 January 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 2
Top Cited PapersOpen AccessThe roles of the nerve-immune axis in modulating bone regeneration
Bone is highly innervated, and its regeneration is significantly nerve-dependent. Extensive evidence suggests that the nervous system plays an active role in bone metabolism and development by modulating osteoblast and osteoclast activity. However, the majority of research to date has focused on the direct effects of peripheral nerves and their neurotransmitters on bone regeneration. Emerging studies have begun to reveal a more intricate role of nerves in regulating the immune microenvironment, which is crucial for bone regeneration. This review summarizes how nerves influence bone regeneration through modulation of the immune microenvironment. We first discuss the changes in peripheral nerves during the regenerative process. We then describe conduction and paracrine pathways through which nerves affect the osteogenic immune microenvironment, emphasizing nerves, neural factors, and their impacts. Our goal is to deepen the understanding of the nerve-immune axis in bone regeneration. A better grasp of how nerves influence the osteogenic immune microenvironment may lead to new strategies that integrate the nervous, immune, and skeletal systems to promote bone regeneration.
- Open Access
- 19 November 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (11) , e70368
Development of a Predictive Model for Large‐Volume Pleural Effusion After Separation Surgery in Patients With Spinal Metastatic Tumors
Background: Separation surgery followed by radiotherapy has emerged as a prevalent approach for managing spinal metastatic tumors. However, large‐volume postoperative pleural effusion (POPE) represents a challenging complication, as it potentially delays subsequent treatments and increases morbidity. This study aims to identify risk factors for large‐volume POPE and develop a predictive model for early identification to improve patient prognosis. Methods: This retrospective study analyzed 443 patients who underwent separation surgery for spinal metastases at our center between January 2014 and January 2022. High‐resolution CT‐based 3D modeling was utilized for accurate pleural effusion (PE) volume quantification. Variables including patient demographics, surgical details, and laboratory results were examined to identify risk factors associated with large‐volume POPE (≥ 1000 mL). A predictive nomogram was developed based on the multivariate logistic regression analysis. Results: Our findings indicated that advanced age, increased intraoperative blood loss, and decreased levels of preoperative serum albumin, postoperative serum protein, and hemoglobin were significant independent risk factors for large‐volume POPE. The predictive nomogram demonstrated high accuracy, with a mean AUC value of 0.953 for the training dataset and 0.927 for the testing dataset, indicating reliable predictability for identifying patients at high risk for large‐volume POPE. Conclusion: Our study identified independent risk factors for large‐volume PE following separation surgery in patients with spinal metastasis. The developed nomogram offers a practical tool for early identification of high‐risk groups, enabling timely and targeted interventions. By reducing the risk of large POPE, this approach may shorten hospitalization and accelerate the resumption of postoperative treatment, ultimately improving patient prognosis.
- 19 November 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (11) , e70368
Open AccessDevelopment of a Predictive Model for Large‐Volume Pleural Effusion After Separation Surgery in Patients With Spinal Metastatic Tumors
Background: Separation surgery followed by radiotherapy has emerged as a prevalent approach for managing spinal metastatic tumors. However, large‐volume postoperative pleural effusion (POPE) represents a challenging complication, as it potentially delays subsequent treatments and increases morbidity. This study aims to identify risk factors for large‐volume POPE and develop a predictive model for early identification to improve patient prognosis. Methods: This retrospective study analyzed 443 patients who underwent separation surgery for spinal metastases at our center between January 2014 and January 2022. High‐resolution CT‐based 3D modeling was utilized for accurate pleural effusion (PE) volume quantification. Variables including patient demographics, surgical details, and laboratory results were examined to identify risk factors associated with large‐volume POPE (≥ 1000 mL). A predictive nomogram was developed based on the multivariate logistic regression analysis. Results: Our findings indicated that advanced age, increased intraoperative blood loss, and decreased levels of preoperative serum albumin, postoperative serum protein, and hemoglobin were significant independent risk factors for large‐volume POPE. The predictive nomogram demonstrated high accuracy, with a mean AUC value of 0.953 for the training dataset and 0.927 for the testing dataset, indicating reliable predictability for identifying patients at high risk for large‐volume POPE. Conclusion: Our study identified independent risk factors for large‐volume PE following separation surgery in patients with spinal metastasis. The developed nomogram offers a practical tool for early identification of high‐risk groups, enabling timely and targeted interventions. By reducing the risk of large POPE, this approach may shorten hospitalization and accelerate the resumption of postoperative treatment, ultimately improving patient prognosis.
- Open Access
- 21 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (12) , eads9581
Selective promotion of sensory innervation–mediated immunoregulation for tissue repair
Sensory innervation triggers the regenerative response after injury. However, dysfunction and impairment of sensory nerves, accompanied by excessive inflammation impede tissue regeneration. Consequently, specific induction of sensory innervation to mediate immunoregulation becomes a promising therapeutic approach. Herein, we developed a cell/drug-free strategy to selectively boost endogenous sensory innervation to harness immune responses for promoting tissue rehabilitation. Specifically, a dual-functional phage was constructed with a sensory nerve–homing peptide and a β-subunit of nerve growth factor (β-NGF)–binding peptide. These double-displayed phages captured endogenic β-NGF and localized to sensory nerves to promote sensory innervation. Furthermore, regarding bone regeneration, phage-loaded hydrogels achieved rapid sensory nerve ingrowth in bone defect areas. Mechanistically, sensory neurotization facilitated M2 polarization of macrophages through the Sema3A/XIAP/PAX6 pathway, thus decreasing the M1/M2 ratio to induce the dissipation of local inflammation. Collectively, these findings highlight the essential role of sensory innervation in manipulating inflammation and provide a conceptual framework based on neuroimmune interactions for promoting tissue regeneration.
- 21 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (12) , eads9581
Open AccessSelective promotion of sensory innervation–mediated immunoregulation for tissue repair
Sensory innervation triggers the regenerative response after injury. However, dysfunction and impairment of sensory nerves, accompanied by excessive inflammation impede tissue regeneration. Consequently, specific induction of sensory innervation to mediate immunoregulation becomes a promising therapeutic approach. Herein, we developed a cell/drug-free strategy to selectively boost endogenous sensory innervation to harness immune responses for promoting tissue rehabilitation. Specifically, a dual-functional phage was constructed with a sensory nerve–homing peptide and a β-subunit of nerve growth factor (β-NGF)–binding peptide. These double-displayed phages captured endogenic β-NGF and localized to sensory nerves to promote sensory innervation. Furthermore, regarding bone regeneration, phage-loaded hydrogels achieved rapid sensory nerve ingrowth in bone defect areas. Mechanistically, sensory neurotization facilitated M2 polarization of macrophages through the Sema3A/XIAP/PAX6 pathway, thus decreasing the M1/M2 ratio to induce the dissipation of local inflammation. Collectively, these findings highlight the essential role of sensory innervation in manipulating inflammation and provide a conceptual framework based on neuroimmune interactions for promoting tissue regeneration.
- Open Access
- 12 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 5 (11) , 1027-1036
Clinical outcomes after extra-articular resection of hip joint tumour using a custom-made osteotomy guide and 3D-printed endoprosthesis with posterior column preserved
Aims: For rare cases when a tumour infiltrates into the hip joint, extra-articular resection is required to obtain a safe margin. Endoprosthetic reconstruction following tumour resection can effectively ensure local control and improve postoperative function. However, maximizing bone preservation without compromising surgical margin remains a challenge for surgeons due to the complexity of the procedure. The purpose of the current study was to report clinical outcomes of patients who underwent extra-articular resection of the hip joint using a custom-made osteotomy guide and 3D-printed endoprosthesis.Methods: We reviewed 15 patients over a five-year period (January 2017 to December 2022) who had undergone extra-articular resection of the hip joint due to malignant tumour using a custom-made osteotomy guide and 3D-printed endoprosthesis. Each of the 15 patients had a single lesion, with six originating from the acetabulum side and nine from the proximal femur. All patients had their posterior column preserved according to the surgical plan.Results: Postoperative pathological assessment revealed a negative surgical margin was achieved in all patients. At final follow-up, 13.3% (2/15) died and no recurrence occurred. The overall survival was 81.7% at five years. None of the patients showed any signs of aseptic loosening, and no wound healing issues were observed. In total, 20% (3/15) developed complications, with two cases of early hip dislocation and one case of deep infection. The cumulative incidence of mechanical and non-mechanical failure in this series was 13.7% and 9.3%, respectively, at five years. In this cohort, the mean time to full weightbearing was 5.89 (SD 0.92) weeks and the mean Musculoskeletal Tumor Society score was 24.1 (SD 4.4).Conclusion: For patients with a hip joint tumour who met the inclusion criteria and were deemed suitable for posterior column preservation, a custom-made osteotomy guide combined with 3D-printed endoprosthesis is worth performing when treating patients who require extra-articular resection of the hip joint, as it can achieve adequate margin for local control, maximize bone preservation to maintain pelvic ring integrity, reduce the risk of complications by simplifying the surgical procedure, and allow for more precise reconstruction for better function.Cite this article: Bone Jt Open 2024;5(11):1027–1036.
- 12 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 5 (11) , 1027-1036
Open AccessClinical outcomes after extra-articular resection of hip joint tumour using a custom-made osteotomy guide and 3D-printed endoprosthesis with posterior column preserved
Aims: For rare cases when a tumour infiltrates into the hip joint, extra-articular resection is required to obtain a safe margin. Endoprosthetic reconstruction following tumour resection can effectively ensure local control and improve postoperative function. However, maximizing bone preservation without compromising surgical margin remains a challenge for surgeons due to the complexity of the procedure. The purpose of the current study was to report clinical outcomes of patients who underwent extra-articular resection of the hip joint using a custom-made osteotomy guide and 3D-printed endoprosthesis.Methods: We reviewed 15 patients over a five-year period (January 2017 to December 2022) who had undergone extra-articular resection of the hip joint due to malignant tumour using a custom-made osteotomy guide and 3D-printed endoprosthesis. Each of the 15 patients had a single lesion, with six originating from the acetabulum side and nine from the proximal femur. All patients had their posterior column preserved according to the surgical plan.Results: Postoperative pathological assessment revealed a negative surgical margin was achieved in all patients. At final follow-up, 13.3% (2/15) died and no recurrence occurred. The overall survival was 81.7% at five years. None of the patients showed any signs of aseptic loosening, and no wound healing issues were observed. In total, 20% (3/15) developed complications, with two cases of early hip dislocation and one case of deep infection. The cumulative incidence of mechanical and non-mechanical failure in this series was 13.7% and 9.3%, respectively, at five years. In this cohort, the mean time to full weightbearing was 5.89 (SD 0.92) weeks and the mean Musculoskeletal Tumor Society score was 24.1 (SD 4.4).Conclusion: For patients with a hip joint tumour who met the inclusion criteria and were deemed suitable for posterior column preservation, a custom-made osteotomy guide combined with 3D-printed endoprosthesis is worth performing when treating patients who require extra-articular resection of the hip joint, as it can achieve adequate margin for local control, maximize bone preservation to maintain pelvic ring integrity, reduce the risk of complications by simplifying the surgical procedure, and allow for more precise reconstruction for better function.Cite this article: Bone Jt Open 2024;5(11):1027–1036.
- Open Access
- 15 October 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (2) , 184-195
3D-Printed Prosthesis with an Articular Interface for Anatomical Acetabular Reconstruction After Type I + II (+ III) Internal Hemipelvectomy
Background: Pelvic reconstruction after type I + II (or type I + II + III) internal hemipelvectomy with extensive ilium removal is a great challenge. In an attempt to anatomically reconstruct the hip rotation center (HRC) and achieve a low mechanical failure rate, a custom-made, 3D-printed prosthesis with a porous articular interface was developed. The aim of this study was to investigate the clinical outcomes of patients treated with this prosthesis. Methods: This retrospective cohort study included 28 patients with type I + II (+ III) internal hemipelvectomy through the articular interface of the sacroiliac joint and managed with a prosthesis at a single center between August 2016 and August 2021. Complications and oncological outcomes were analyzed. The position of the reconstructed HRC was assessed and lower-limb function was evaluated. Biomechanical analyses of different fixation modes of the prosthesis were conducted using finite element analysis. Results: The displacement distance of the HRC from preoperatively to postoperatively was a mean (and standard deviation) of 14.12 ± 8.75 mm. The rate of implant-related complications was 14.3% (4 of 28) for prosthetic breakage, 14.3% (4 of 28) for aseptic loosening, 7.1% (2 of 28) for dislocation, and 7.1% (2 of 28) for deep infection. The mean Musculoskeletal Tumor Society (MSTS)-93 score was 18.2. The aseptic loosening rate was significantly greater for prostheses fixed with 3 sacral screws (4 of 10, 40.0%) than for those fixed with 4 (0 of 10, 0%) or 5 screws (0 of 8, 0%) (p = 0.024). The prosthetic breakage rate was lower in patients who underwent lumbosacral fixation (0 of 13, 0%) than in those who did not (4 of 15, 26.7%), although the difference did not reach significance (p = 0.102). Biomechanical analyses suggested that the addition of lumbosacral fixation or increasing the number of sacral screws from 3 to 4 or 5 visibly reduced the peak stress of the sacral screws. Conclusions: The use of a 3D-printed prosthesis with an articular interface for pelvic reconstruction demonstrated stable prosthetic fixation, anatomical acetabular reconstruction, and acceptable early functional outcomes. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 15 October 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (2) , 184-195
Open Access3D-Printed Prosthesis with an Articular Interface for Anatomical Acetabular Reconstruction After Type I + II (+ III) Internal Hemipelvectomy
Background: Pelvic reconstruction after type I + II (or type I + II + III) internal hemipelvectomy with extensive ilium removal is a great challenge. In an attempt to anatomically reconstruct the hip rotation center (HRC) and achieve a low mechanical failure rate, a custom-made, 3D-printed prosthesis with a porous articular interface was developed. The aim of this study was to investigate the clinical outcomes of patients treated with this prosthesis. Methods: This retrospective cohort study included 28 patients with type I + II (+ III) internal hemipelvectomy through the articular interface of the sacroiliac joint and managed with a prosthesis at a single center between August 2016 and August 2021. Complications and oncological outcomes were analyzed. The position of the reconstructed HRC was assessed and lower-limb function was evaluated. Biomechanical analyses of different fixation modes of the prosthesis were conducted using finite element analysis. Results: The displacement distance of the HRC from preoperatively to postoperatively was a mean (and standard deviation) of 14.12 ± 8.75 mm. The rate of implant-related complications was 14.3% (4 of 28) for prosthetic breakage, 14.3% (4 of 28) for aseptic loosening, 7.1% (2 of 28) for dislocation, and 7.1% (2 of 28) for deep infection. The mean Musculoskeletal Tumor Society (MSTS)-93 score was 18.2. The aseptic loosening rate was significantly greater for prostheses fixed with 3 sacral screws (4 of 10, 40.0%) than for those fixed with 4 (0 of 10, 0%) or 5 screws (0 of 8, 0%) (p = 0.024). The prosthetic breakage rate was lower in patients who underwent lumbosacral fixation (0 of 13, 0%) than in those who did not (4 of 15, 26.7%), although the difference did not reach significance (p = 0.102). Biomechanical analyses suggested that the addition of lumbosacral fixation or increasing the number of sacral screws from 3 to 4 or 5 visibly reduced the peak stress of the sacral screws. Conclusions: The use of a 3D-printed prosthesis with an articular interface for pelvic reconstruction demonstrated stable prosthetic fixation, anatomical acetabular reconstruction, and acceptable early functional outcomes. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 1 October 2024
- Published by American Association for Cancer Research (AACR)
Data from First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial
Purpose:Standard treatment for patients with unresectable locally advanced or metastatic soft-tissue sarcoma (LA/M STS) is chemotherapy based on anthracyclines, but patient tolerance of chemotherapy is limited. The present trial (NCT03792542) investigated the use of anlotinib as first-line treatment for patients with advanced STS, in particular liposarcoma.Patients and Methods:Eligible patients were previously untreated, pathologically confirmed, unresectable LA/M STS cases. Anlotinib was given orally at a dose of 12 mg once daily from days 1 to 14 every 3 weeks until disease progression or intolerable adverse events (AE) occurred. The primary endpoint was progression-free survival (PFS), and the secondary endpoints were overall survival (OS), objective response rate, and disease control rate (DCR). The safety profile was also evaluated.Results:Forty patients were enrolled from April 2019 to June 2022 and are included in the intention-to-treat analysis. The median PFS was 6.83 months [95% confidence interval (CI), 4.17–8.71] and the median OS 27.40 months (95% CI, 16.43–not evaluable); 1 patient reached partial response and 26 attained stable disease, with a DCR of 67.5% (27/40). Median PFS and OS times for liposarcoma patients were 8.71 and 16.23 months, respectively. Ten (25.0%) patients had treatment-related AEs ≥ grade 3, with in particular a higher incidence of hypertension (15.0%) and proteinuria (7.5%).Conclusions:The findings suggest a potential benefit in using front-line anlotinib to treat patients with STS, who are not eligible for cytotoxic chemotherapy. Of note, the clinical outcomes for the liposarcoma subgroup of patients were encouraging.See related commentary by Napolitano et al., p. 4257
- 1 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial
Purpose:Standard treatment for patients with unresectable locally advanced or metastatic soft-tissue sarcoma (LA/M STS) is chemotherapy based on anthracyclines, but patient tolerance of chemotherapy is limited. The present trial (NCT03792542) investigated the use of anlotinib as first-line treatment for patients with advanced STS, in particular liposarcoma.Patients and Methods:Eligible patients were previously untreated, pathologically confirmed, unresectable LA/M STS cases. Anlotinib was given orally at a dose of 12 mg once daily from days 1 to 14 every 3 weeks until disease progression or intolerable adverse events (AE) occurred. The primary endpoint was progression-free survival (PFS), and the secondary endpoints were overall survival (OS), objective response rate, and disease control rate (DCR). The safety profile was also evaluated.Results:Forty patients were enrolled from April 2019 to June 2022 and are included in the intention-to-treat analysis. The median PFS was 6.83 months [95% confidence interval (CI), 4.17–8.71] and the median OS 27.40 months (95% CI, 16.43–not evaluable); 1 patient reached partial response and 26 attained stable disease, with a DCR of 67.5% (27/40). Median PFS and OS times for liposarcoma patients were 8.71 and 16.23 months, respectively. Ten (25.0%) patients had treatment-related AEs ≥ grade 3, with in particular a higher incidence of hypertension (15.0%) and proteinuria (7.5%).Conclusions:The findings suggest a potential benefit in using front-line anlotinib to treat patients with STS, who are not eligible for cytotoxic chemotherapy. Of note, the clinical outcomes for the liposarcoma subgroup of patients were encouraging.See related commentary by Napolitano et al., p. 4257
- Open Access
- 1 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data 1 from First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial
Supplementary File 1. Inclusion and exclusion criteria.Supplementary Table S1. Representativeness of trial patients.Supplementary Table S2. Summary of adverse events.
- 1 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 1 from First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial
Supplementary File 1. Inclusion and exclusion criteria.Supplementary Table S1. Representativeness of trial patients.Supplementary Table S2. Summary of adverse events.
- 5 June 2024
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 34 (6) , 2963-2972
Novel positioning guiders accurately assist in situ acetabular reconstruction for patients undergoing pelvic bone tumor resection
Purpose Acetabular reconstruction in situ after extensive pelvic resection is technically challenging. The aim of this study was to investigate the feasibility of positioning guiders for acetabular reconstruction following pelvic tumor resection and the clinical benefit brought by the approach. Methods The study included patients who underwent acetabular reconstruction following periacetabular tumor resection using a modular hemipelvic prosthesis. In the guider-assisted group (n = 14), guiders were designed and applied to assist acetabular reconstruction. In the traditional operation group (n = 18), the patients underwent the same surgery but without the guiders. The displacement of the hip rotation center before and after surgery was calculated. The complications and the Musculoskeletal Tumor Society—93 scores were documented. Results The overall displacement of the hip rotation center was significantly reduced in the guider-assisted group compared with the traditional operation group (13.83 ± 4.06 vs. 22.95 ± 9.18 mm in P = 0.000, 95%CI 3.90–12.96), especially in the anteroposterior axis (3.77 ± 3.03 versus 13.51 ± 9.43 mm in P = 0.000, 95%CI 3.45–13.09). Guider-assisted acetabular reconstruction reduced the risk of prosthesis dislocation compared with the traditional operation (dislocation risks: 1/14, 7.1% vs. 4/18, 22.2%). Conclusion Positioning guiders can effectively and conveniently help place the modular hemipelvic prosthesis at the native position, which might potentially reduce the risk of prosthesis dislocation. Level of evidence Therapeutic level III.
- 5 June 2024
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 34 (6) , 2963-2972
Novel positioning guiders accurately assist in situ acetabular reconstruction for patients undergoing pelvic bone tumor resection
Purpose Acetabular reconstruction in situ after extensive pelvic resection is technically challenging. The aim of this study was to investigate the feasibility of positioning guiders for acetabular reconstruction following pelvic tumor resection and the clinical benefit brought by the approach. Methods The study included patients who underwent acetabular reconstruction following periacetabular tumor resection using a modular hemipelvic prosthesis. In the guider-assisted group (n = 14), guiders were designed and applied to assist acetabular reconstruction. In the traditional operation group (n = 18), the patients underwent the same surgery but without the guiders. The displacement of the hip rotation center before and after surgery was calculated. The complications and the Musculoskeletal Tumor Society—93 scores were documented. Results The overall displacement of the hip rotation center was significantly reduced in the guider-assisted group compared with the traditional operation group (13.83 ± 4.06 vs. 22.95 ± 9.18 mm in P = 0.000, 95%CI 3.90–12.96), especially in the anteroposterior axis (3.77 ± 3.03 versus 13.51 ± 9.43 mm in P = 0.000, 95%CI 3.45–13.09). Guider-assisted acetabular reconstruction reduced the risk of prosthesis dislocation compared with the traditional operation (dislocation risks: 1/14, 7.1% vs. 4/18, 22.2%). Conclusion Positioning guiders can effectively and conveniently help place the modular hemipelvic prosthesis at the native position, which might potentially reduce the risk of prosthesis dislocation. Level of evidence Therapeutic level III.